A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults (NCT07382167)
A 26-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Tenapanor for the Treatment of Chronic Idiopathic Constipation (CIC) in Adults
🩺 Plain-English Summary (8th-Grade Level)
This is a 26-week, multi-center, randomized, double-blind, placebo-controlled study with a 4-week treatment-free Safety Follow-up period to assess the safety and efficacy of tenapanor (5 mg, 25mg, and 50 mg) in adult patients with Chronic Idiopathic Constipation (CIC) when administered twice daily for 26 consecutive weeks.
Who can join: Review the eligibility criteria below.
Location: G & L Research, LLC — Foley, Alabama
Age range: 18 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (109 Sites)
Showing the first 25 of 109 sites.
- G & L Research, LLC — Foley, Alabama
- The Center for Clinical Trials — Saraland, Alabama
- Arizona Liver Health - Chandler — Chandler, Arizona
- Elite Clinical Studies — Phoenix, Arizona
- Clinical Research Institute of Arizona, LLC — Sun City West, Arizona
- Del Sol Research Management, LLC — Tucson, Arizona
- Arkansas Gastroenterology - North Little Rock — North Little Rock, Arkansas
- Hope Clinical Research - Canoga Park — Canoga Park, California
- GW Research Inc. — Chula Vista, California
- Erick H. Alayo Medical Corporation — Chula Vista, California
- 310 Clinical Research — Inglewood, California
- Om Research LLC — Lancaster, California
- Clinical Trials Research — Lincoln, California
- Acclaim Clinical Research — San Diego, California
- San Jose Gastroenterology — San Jose, California
- Paragon Rx Clinical, Inc. - Santa Ana — Santa Ana, California
- Advanced Research Institute - Denver — Denver, Colorado
- Rocky Mountain Gastroenterology (RMG) - Littleton — Lakewood, Colorado
- Tekton Research - Longmont, CO — Longmont, Colorado
- Proactive Clinical Research — Fort Lauderdale, Florida
- Waterway Research — Miami, Florida
- Valencia Medical and Research Center — Miami, Florida
- IMIC, Inc — Miami, Florida
- Harmony Clinical Research, Inc - North Miami Beach — Miami Beach, Florida
- Suncoast Clinical Research, Inc. - New Port Richey — New Port Richey, Florida
📞 Contact the Study Coordinator
Phone: (617) 875-7968
Email: mtambongco@ardelyx.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Chronic Idiopathic Constipation (CIC)
- Post-Marketing Study of Prucalopride Safety In Pregnancy — La Jolla, California
- A Study of Prucalopride in Breastfeeding Women With Constipation — La Jolla, California
Explore by condition: All Chronic Idiopathic Constipation (CIC) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.